Empress Therapeutics
United States · Founded 2020 · $50.0M raised
- Founded
- 2020
- Business Model
- B2B
- Website
- empresstx.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series AJun 2023
- Rounds
- 1
About
Drug discovery company using human body chemistry and genetics to generate medicines faster.
Summary
Empress Therapeutics is a Biotech company based in United States, founded in 2020. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in Jun 2023. Investors include Flagship Pioneering and J2 Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2023
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...